Brian Hilberdink
President of U.S. Human Pharma at Boehringer Ingelheim, with prior leadership roles at LEO Pharma and over two decades at Novo Nordisk, experienced in commercialization across cardiometabolic, dermatology, oncology and respiratory therapeutic areas.
Best podcasts with Brian Hilberdink
Ranked by the Snipd community
12 snips
Jan 28, 2026 • 22min
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim with 25+ years in commercial leadership. He recalls an unconventional path from sales to pharma leadership. They explore Boehringer’s private, R&D-first model and its pipeline in obesity, CKD, ILD and oncology. The conversation covers modern commercial moves like DTC, digital engagement, AI-driven launches, and China’s role in innovation.
4 snips
Feb 2, 2026 • 45min
BoB@JPM: Brian Hilberdink, Boehringer Ingelheim
Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim and veteran commercial leader, discusses new opportunities in obesity and upcoming launch priorities. He explains how private ownership shapes long-term R&D, Boehringer's deal focus and adjacencies, and using AI to sharpen commercialization. He also covers market conditioning, CKD awareness, and regulators speeding HER2 NSCLC review.
